Katherine Goodrich

TARS

Katherine Goodrich serves as director at Tarsus Pharmaceuticals, Inc. (TARS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$183.4K

Net Position

Net Seller

$183.4K

Companies Traded

TARS

Active Period

Jun 2026

1 total trades

Most Recent

Sell TARS

Jun 17, 2026 · $183.4K

Katherine Goodrich's Insider Trading at Tarsus Pharmaceuticals, Inc. (TARS)

Buys

0 · $0.00

Sells

1 · $183.4K

Total Shares Bought

Total Shares Sold

2,954

TARS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 17, 2026	Sell	2,954	$62.08	$183.4K	2,233

Related Insiders

Bobak R. Azamian

President/CEO and Board Chair

TARSSell · Jun 22, 2026

Jeffrey S Farrow

officer: See Remarks

TARSSell · Jun 17, 2026

LINK WILLIAM J PHD

Director

TARSSell · Jun 17, 2026

Seshadri Neervannan

officer: Chief Operating Officer

TARSSell · Mar 24, 2026

Dianne C. Whitfield

officer: Chief Human Resources Officer

TARSSell · Mar 19, 2026

Elizabeth Yeu Lin

officer: Chief Medical Officer

TARSSell · Mar 19, 2026

Aziz Mottiwala

officer: Chief Commercial Officer

TARSSell · Mar 19, 2026

Bryan Wahl

officer: General Counsel

TARSSell · Mar 19, 2026

Explore More Insider Trading Data

TARS Insider Trading Activity

View all insider trades at Tarsus Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity